By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ocular Therapeutix, Inc. 

204 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


SEARCH JOBS


Industry
Biotechnology






Company News
Ocular Therapeutix (OCUL) To Participate At The Cantor Fitzgerald Inaugural Healthcare Conference 6/30/2015 11:17:39 AM
Ocular Therapeutix (OCUL) Begins Enrollment In Phase 3 Clinical Trial For DEXTENZA For The Treatment Of Allergic Conjunctivitis 6/16/2015 11:29:06 AM
Ocular Therapeutix (OCUL) Announces Pricing Of Public Offering Of Common Stock 6/5/2015 10:40:20 AM
Ocular Therapeutix (OCUL) Announces Proposed Public Offering Of Common Stock 6/3/2015 10:30:01 AM
Ocular Therapeutix (OCUL) Announces Plans To Proceed With An NDA Submission For OTX-DP For Treatment Of Post-Surgical Ocular Pain Indication; Reports First Quarter 2015 Financial Results 5/15/2015 12:00:24 PM
Ocular Therapeutix (OCUL) To Report First Quarter 2015 Financial Results 5/7/2015 12:38:24 PM
Ocular Therapeutix (OCUL) To Present Eight Posters Highlighting Its Sustained Release Hydrogel Platform Technology At The Association for Research in Vision & Ophthalmology Annual Meeting 5/1/2015 11:10:34 AM
Ocular Therapeutix (OCUL) Reports Topline Clinical Data For Its Second Phase 3 Clinical Trial Evaluating OTX-DP For The Treatment Of Post-Surgical Ocular Inflammation And Pain 4/7/2015 6:45:06 AM
Ocular Therapeutix (OCUL) Stock Caves After Eye Pain Drug Flunks Pivotal Trial 4/7/2015 6:39:26 AM
Ocular Therapeutix, Inc. (OCUL) Reports Fourth Quarter And Full Year 2014 Financial Results 3/10/2015 11:13:52 AM
123456
//-->